18 results with keyword: 'cancer stem cells as targets for immunotherapy'
Cell surface antigens, expressed on CSCs, such as CD44, CD133, aldehyde dehydrogenases (ALDH) and EpCAM can be targeted this way.. Preclinical work using these CAR T cells
N/A
MUPBED: one e2e connection GINS MPLS Service GINS MPLS Service SNMP Polls Informations on: 1- LSP1 2- L2 connection Informations on: 1- LSP1 2- L2 connection TO MI2 MI1 GN2 IT GN2
N/A
Dr. Daniel Powell from the University of Pennsylva- nia presented his group’s efforts to design innovative T cell based therapies for cancer, based on lentiviral gene transfer
N/A
Cancer stem cells • Cell signaling • Differentiation • Self-renewal • Tissue-specific stem cells • Signal transduction • Targeted therapy • Drug
N/A
© Annals of Translational Medicine All rights reserved Ann Transl Med 2016;4(24) 518atm amegroups com Page 1 of 8 Perspective Aldehyde dehydrogenases in cancer stem cells potential
N/A
As for CAR adoptive cellular immunotherapy in ovarian cancers, the first-generation CAR design targeting α -folate receptor (FR) was first practiced clinically in patients with
N/A
Keywords: Ewing’s Sarcoma Family of Tumors; Cancer Stem Cells; Immunotherapy; Hematopoietic Progenitor Cell Transplant; Diagnostic Strategies; ESFT
N/A
The tumor vasculature support growth and survival of tumor cells by releasing tumorigenic factors (ex.EGF, HGF), impeding drug delivery and entry of effector immune cell
N/A
In particular, we discuss the differences between the major carcinogenesis models (ie, clonal evolution vs cancer stem cell (CSC) model) with emphasis on breast cancer (given
N/A
For the immunization, the different amounts of immunogen were emulsified in Immune- stimulating oil emulsion and injected according to the several multisite
N/A
Cancer Subclones Derived from the Patient's Head and Neck Squamous Cell Carcinoma Tumor Stem Cells for the Screening of Personalized Antitumor Immunotherapy and
N/A
Background: To study the frequency and pattern of use of complementary and alternative medicine (CAM) in patients with essential hypertension attending a tertiary hypertension
N/A
CBR: Clinical benefit rate; CI: Confidence interval; CIK: Cytokine-induced killer; CIT: Cellular immunotherapy; CR: Complete remission; CT: Computed tomography; CSCs: Cancer stem
N/A
114 The United States uses this price-setting tactic (for medical services) in its Medicare system, 115 yet no attempt to expand Medicare or create a Medicare- based public
N/A
When the diagnostic statement records two or more independent primary malignant neoplasms none of which clearly predominates, code C97.X is assigned as the main condition.
N/A
AN ACT relating to wildlife; creating the Advisory Council on Nevada Wildlife Conservation and Education; prescribing the membership and duties of the Council; creating the
N/A
Such recipient cells include various immune cells, cancer cells themselves, as well as potential cancer stem cells [CSC, also known as cancer-initiating cells (CIC)], epithelial cells
N/A
Metabolic reprogramming in cancer cells glycolysis, glutaminolysis, and Bcl 2 proteins as novel therapeutic targets for cancer REVIEW Open Access Metabolic reprogramming in cancer
N/A